Medicus Pharma Eyes Pivotal Trial for Novel Skin Cancer Therapy as Phase 2 Enrollment Progresses | TSX-V:MDCX, NASDAQ:MDCX

Proactive Investors12/03 03:44

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

newsfile12/02 20:30

6-K：海外発行者報告書（決算情報）

SEC11/25 21:02

Medicus Pharma Unveils Ex-GSK and Pfizer Senior as Chief Medical Officer | TSX-V:MDCX, NASDAQ:MDCX

Proactive Investors11/18 21:44

Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Dow Jones11/18 20:30

Medicus Pharma Shares Fall After IPO

WSJ11/15 03:26